RSP-1502
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Respirion Pharmaceuticals Pty Ltd
Overview
RSP-1502 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
RSP-1502 clinical trials
Explore related
Medical disclaimer. This page summarizes research about RSP-1502 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.